What is Amfora?
Based in San Francisco, CA, Amfora operates within the biotechnology industry, with a distinct focus on advancing nutritional crop development. The company leverages scientific innovation to enhance the nutritional value and yield of crops, addressing critical needs in global food security and health. Its strategic positioning in the AgTech space suggests a commitment to sustainable agricultural practices and the development of high-value agricultural products.
How much funding has Amfora raised?
Amfora has raised a total of $12M across 2 funding rounds:
Series A
$5M
Series B
$7M
Series A (2017): $5M with participation from Spruce Capital and Commonwealth Scientific Industrial Research Organization (CSIRO)
Series B (2021): $7M led by Leaps by Bayer, Spruce Capital Partners, and BayWa
Key Investors in Amfora
Spruce Capital Partners
Spruce Capital Partners is a venture capital management firm based in San Francisco that focuses on investing in and building innovative companies in the Ag, Nutrition, and Industrial Life Sciences sectors. The firm aims to create, advise, and invest in life sciences companies that have a positive impact on the environment and enhance human health and wellness.
BayWa
Founded in 1923, BayWa provides services across a multitude of business segments including agricultural, construction, and energy industries. Their involvement ranges from material retail to energy distribution, with a strong presence in Bavaria, Germany.
Leaps by Bayer
Leaps by Bayer is the venture capital arm of Bayer AG, focused on investing in breakthrough technologies in life sciences, including agriculture and healthcare. They aim to drive innovation and address global challenges through strategic investments in early-stage companies.
What's next for Amfora?
The recent major strategic investment positions Amfora for accelerated scaling and further research and development initiatives. This enterprise-level funding is indicative of a company in a significant growth phase, likely focused on expanding its product pipeline, optimizing its cultivation technologies, and potentially entering new markets. The backing from strategic investors suggests a validation of Amfora's business model and its potential to disrupt the agricultural and nutritional sectors.
See full Amfora company page
